The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?

Bill D. Gogas; Vasim Farooq; Yoshinobu Onuma; Patrick W. Serruys

The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?

PubMed 53(4): 301-9

Article 2012 English

Related publications

Article2012

The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?

Bill D. Gogas, Vasim Farooq, Yoshinobu Onuma, Patrick W. Serruys

Article2014

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold

Bernard De Bruyne, Gábor G. Tóth, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2015

DIFFERENCES IN THE OCCURRENCE OF NEW OR WORSENING ANGINA BETWEEN THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD AND XIENCE METALLIC STENT: A POST-HOC ANALYSIS OF THE ABSORB II RANDOMIZED TRIAL

Bernard Chevalier, Maik J. Grundeken, Roseann White, Yuki Ishibashi, Héctor García García, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2013

Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment

Héctor M. García‐García, Carl Schultz, Eric Duckers, Evelyn Regar, Jürgen Ligthart, Patrick W. Serruys, Robert‐Jan van Geuns

EuroIntervention

Article2016

TCT-431 RANDOMIZED COMPARISON OF ABSORB BIORESORBABLE VASCULAR SCAFFOLD AND MIRAGE MICROFIBER SIROLIMUS ELUTING SCAFFOLD USING MULTI-MODALITY IMAGING

Teguh Santoso, Huong Bang Liew, Erhan Tenekecioğlu, Ricardo A. Costa, Daniel Chamié, Solomon Su, Alexandre Abizaid, Christos V. Bourantas, Ryo Torii, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?

Abstract

Discussion(0)

Related publications

The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold

DIFFERENCES IN THE OCCURRENCE OF NEW OR WORSENING ANGINA BETWEEN THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD AND XIENCE METALLIC STENT: A POST-HOC ANALYSIS OF THE ABSORB II RANDOMIZED TRIAL

Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment

TCT-431 RANDOMIZED COMPARISON OF ABSORB BIORESORBABLE VASCULAR SCAFFOLD AND MIRAGE MICROFIBER SIROLIMUS ELUTING SCAFFOLD USING MULTI-MODALITY IMAGING